Tag: AU-011

Aura Biosciences gets FDA fast track status for belzupacap sarotalocan

pallavi123- July 3, 2022

Aura Biosciences has secured fast track designation for belzupacap sarotalocan (AU-011) from the US Food and Drug Administration (FDA) for the treatment of non-muscle invasive ... Read More

Aura Biosciences raises $80m for VDC therapies for cancers

pallavi123- March 22, 2021

Aura Biosciences, a portfolio company of UK-based Arix Bioscience, has raised $80 million in a new funding round for developing virus-like drug conjugate (VDC) therapies ... Read More